News
Complete Tutorial for Protein Phylogenetic Analysis workflow
Build accurate evolutionary trees with one click: from sequence alignment to smart visualization, the MatwingsVenus™ (XiaoWu™) platform combines cloud computing power and AI parameter suggestions, cutting protein phylogenetic analysis from days down to just hours, directly tackling the core biological questions of functional evolution and targeted modification.
Aug 13, 2026
AlphaFold Protein Structure Prediction Tutorial
A lot of people use AlphaFold, but when faced with a structure diagram, they don't know what to do next. The MatwingsVenus™ (XiaoWu™) platform, however, builds on structure prediction and integrates full-chain capabilities from structure quality assessment, functional site mining, stability and property analysis, to intelligent design for directed evolution, making predicted structures actually 'useful' instead of just taking up space on your hard drive.
Aug 13, 2026
How to look at AlphaFold structure results? From prediction to experimental decisions
How can we judge the reliability of protein structures predicted by AlphaFold? The key is understanding the pLDDT and PAE indicators—deep blue areas are safe to use, yellow areas should be treated with caution. Meanwhile, MatwingsVenus (Xiaowu) is integrating structure interpretation, functional annotation, and protein design into a full-process smart R&D workflow.
Aug 13, 2026
Recommended Protein Sequence Clustering Software: A Full Comparison of Online AI Platforms and Local Tools
When it comes to clustering millions of protein sequences, traditional tools are limited by computing power and technical barriers. The new-generation online platform MatwingsVenus combines large model embeddings for clustering, completing analyses in minutes and generating interactive reports with a single click, turning massive data into biological insights instantly.
Aug 12, 2026
How to Find Protein Conserved Sites? A Complete Guide from Sequence Alignment to Intelligent Analysis
Accurately identifying conserved sites in proteins is key to understanding their function and guiding targeted modifications. From multiple sequence alignment to AI-powered analysis, mastering these essential methods can really boost your research efficiency.
Aug 12, 2026
How to do multiple sequence alignment of proteins?
Multiple sequence alignment is the starting point for almost all protein sequence analysis. Sequence annotation, function prediction, homology modeling, evolutionary analysis... almost all downstream analyses are built on a high-quality multiple sequence alignment. That's also why 'how to do protein multiple sequence alignment' is a basic skill every bioinformatician can't avoid.
Aug 12, 2026
Recommended Online Tools for Protein Sequence Function Prediction: How Can an All-in-One AI Platform Beat Traditional Toolchains?
In today's age of exploding proteomics data, Matwings Technology's MatwingsVenus platform uses a massive sequence database and protein language models to provide an all-in-one analysis from amino acid sequences to functional annotation and active site prediction, compressing traditional multi-month experimental cycles down to minutes, offering efficient and smart solutions for synthetic biology and drug development.
Aug 11, 2026
Protein Sequence and Function Relationship: Three-Layer Mapping, Three Major Dilemmas, and New Solutions in the AI Era
How can AI crack the ultimate code linking protein sequences to their functions? From AlphaFold's breakthroughs to AI-driven enzyme engineering, we're standing at the forefront of a protein engineering revolution—how does an amino acid sequence determine function? Structure prediction is just the start; the real challenge lies in understanding the complex mapping from sequence to function.
Aug 11, 2026
Protein Sequence Analysis Software Recommendations: More Than Just Queries, It's R&D
Protein sequence analysis no longer requires constantly switching tools—MatwingsVenus puts AI at the core, enabling parallel searches across 30 databases, and lets natural language drive design and experiments, cutting the traditional 2-5 year R&D cycle down to 2-6 months, making 'chat-based protein development' a reality.
Aug 11, 2026
Protein G pre-packed column or Protein G agarose resin? Understand how to choose in 5 minutes
Protein G has become the preferred choice for antibody purification thanks to its broader species compatibility and lower non-specific binding. The key to selecting it: use pre-packed columns for small samples and be flexible with bulk resin for larger samples. AI-designed domestic Protein G products have made breakthroughs in capacity, stability, and cost, supporting both research and industrial-scale purification.
Aug 11, 2026
AAV Virus Vector Purification Media and AAV Affinity Chromatography Materials: The 'Purification Code' of Gene Therapy and New AI Solutions
The key to the million-dollar cost of gene therapy lies in purification—AAV affinity chromatography media acts like a precise molecular key, capturing the target virus in one step and boosting purity by over 90%. AI agents are reshaping the way we develop these resins, making high-efficiency purification no longer a bottleneck.
Aug 11, 2026
Fab purified Protein L resin and scFv purified Protein L resin: the "exclusive key" for antibody fragment purification
For full IgG and other antibodies with the complete Fc region, Protein A resins are preferred since they offer higher industrial capacity and a more mature process. For Fab, scFv, and other antibodies without an Fc fragment, you have to use Protein L resins for Fab or Protein L resins for scFv purification.
Aug 11, 2026
Kappa Light Chain Purification Resins / Kappa Light Chain Affinity Resins: Principles, Applications, and Selection Guide
Traditional Protein A resins can't purify new types of antibodies? κ light chain affinity resins are exactly that 'second key,' specially solving purification challenges for Fab fragments, bispecific antibodies, and more. With AI optimization, their performance is even stronger, coverage is broader, helping you break through process bottlenecks.
Aug 10, 2026
Rabbit IgG Purification Media / Human IgG Purification Media / IgG Subclass Purification Media: The Complete Guide to Choosing
For rabbit IgG, Protein A is the first choice. For human IgG1/2/4, use Protein A, and for IgG3, go with Protein G — picking the right resin can boost antibody recovery by 30%. AI-designed affinity chromatography materials are tailored to match subtype characteristics, solving the IgG3 purification challenge.
Aug 9, 2026
How to choose AAV resins? This article explains the differences and selection of AAV affinity resins, AAV chromatography resins, and AAV purification resins
The core battlefield of gene therapy is hidden in the little 'bottles and jars' of AAV fillers—ranging from star vectors in the hundred-billion-level market to the tough purification tests. With just one step, affinity fillers that can capture high-purity AAV are breaking the industry's 'no fillers available' dilemma through AI-driven precision design.
Aug 9, 2026
Complete Guide to IgG Purification with Protein G: Choosing Multi-Species IgG Purification Media and Practical Tips for Mouse/Rat IgG Purification
Protein A resin has very weak binding ability to rodent IgG subclasses, like those from mice and rats, so it’s not suitable for purifying rodent antibodies. On the other hand, Protein G resin, with its broad species compatibility, has become a go-to choice for purifying IgG across multiple species, making it the key solution for the tricky task of selecting resins for mouse and rat IgG purification.
Aug 6, 2026
Protein A pre-packed columns, chromatography columns, capture steps, and process development
Protein A pre-packed columns, chromatography columns, capture steps, and process development: A full breakdown of antibody purification from lab to mass production;The global chromatography media market is expected to reach $3 billion by 2025. Protein A, as the core technology for antibody purification, can boost antibody purity to over 95% in just one capture step. Domestic alternatives are speeding up, and AI technology is reshaping Protein A media development, pushing China's antibody industry towards greater self-reliance.
Aug 6, 2026
Protein L Affinity Ligands: Why Can They Capture Antibodies That Protein A Cannot?
Protein L breaks the traditional Fc-dependent antibody recognition mechanism. By binding to the variable region of the κ light chain, it can efficiently capture antibodies, perfectly matching new antibody drugs like Fab and scFv that lack Fc structures, making it a key material for industrial purification. AI-driven ligand optimization also gives it high load capacity, alkali resistance, and precise separation ability, pushing antibody drug production into the era of smart manufacturing.
Aug 6, 2026
Protein L Resin vs. Recombinant Protein L Resins: Filling the Key Piece in Antibody Fragment Purification
Protein L resin breaks through the limitations of traditional antibody purification. By binding to the κ light chain variable region, it creates an efficient purification path for antibody fragments without Fc structures, like Fab, scFv, and bispecific antibodies, making it an indispensable tool in new antibody drug development. Protein L resin; Protein L resin suppliers.
Aug 5, 2026
What is a Protein G ligand? Principles, parameters, and selection guide for Protein G affinity ligands
Protein G affinity ligands, with their broad-spectrum antibody binding, low non-specific adsorption, and flexible elution features, have become a key solution for purifying antibodies from multiple species. The AI-optimized version breaks through traditional performance limits, achieving a balance of high stability and high specificity, covering all scenarios in research, diagnostics, and biomanufacturing. Protein G affinity ligand manufacturers.
Aug 5, 2026
Protein G Resin (Affinity/Chromatography) Principles, Parameters, and Applications｜Guide to Choosing Recombinant Protein G Resin
Protein G affinity media, with its broader antibody binding ability and lower non-specific adsorption, has become a core material for research diagnostics and antibody purification. It's especially useful for subtypes that Protein A struggles to capture, like human IgG3 and mouse IgG1. Recombinant Protein G, designed with AI, further improves binding capacity, alkali resistance, and specificity, making antibody purification more efficient and stable.
Aug 4, 2026
Antibody downstream purification resins: A full view of Protein A resins from industrial to commercial use
The core of commercializing antibody drugs lies in Protein A resins—from the high load demands of lab-scale process scale-up to cost control in large-scale production, every step relies on the resin's precise performance. AI-powered MatwingsVenus is reshaping this tech foundation, helping domestic resins overcome both performance and supply chain barriers.
Aug 4, 2026
pH 5 Elution Protein A Resins: Can They Solve the Purification Challenges of Acid-Sensitive Antibodies?
The traditional strong-acid elution mode of Protein A affinity chromatography is being disrupted by the mild pH 5 elution technique! The new monomer-protected resin allows sensitive molecules like bispecific and polyclonal antibodies to avoid structural collapse, enabling high-load purification at higher pH, preventing aggregation from the start, and improving both yield and purity.
Aug 4, 2026
A Deep Dive into China Protein A Resins: The Road to Replacing Imported Affinity Chromatography Resins
China Protein A resins are moving from being a 'cheap alternative' to a 'high-quality alternative.' AI-assisted ligand design has shortened the R&D cycle from 2-5 years to 2-6 months and reduced the number of experimental samples by over 90%, becoming a key technological breakthrough for breaking import monopolies and achieving independent control of high-end chromatography resins.
Aug 3, 2026
A complete guide to purifying monoclonal antibodies, bispecific antibodies, Fc fusion proteins, and ADCs using Protein A resin
Antibody drug purification technology is going through a revolutionary upgrade: from the classic three-step purification for monoclonal antibodies to special resins for bispecific antibodies/ADCs, the AI-driven MatwingsVenus smart system is reshaping the paradigm of chromatography media design, making high-purity, low-cost production possible — China's path to self-reliant biopharmaceuticals lies in these tiny technical breakthroughs.
Aug 3, 2026
Low-pH Sensitive Antibody Purification Resins: When Antibodies "Fear Acid," How Does the Process Break Through?
With the development of new antibody drugs, complex molecules like bispecific or multispecific antibodies are extremely sensitive to acidic environments, and traditional strong acid elution processes can easily damage their structure. Purification resins for low pH-sensitive antibodies use ligand engineering and specific modifications to enable gentle high-pH elution and precise impurity removal, solving the industrial purification challenges of acid-sensitive and easily aggregated antibodies and becoming a core technology supporting biopharmaceutical production.
Aug 3, 2026
Customized Chromatography Media and Affinity Ligands: The Personalized Upgrade Path for Biopharmaceutical Purification Media
Biopharmaceutical purification costs account for 50%-80% of total production costs, and custom chromatography fillers combined with AI-designed affinity ligands are becoming key to cost reduction. From standardization to personalization, next-generation purification technologies will break through the process bottlenecks of complex drugs such as bispecific antibodies and ADCs. The MatwingsVenus platform enables efficient customization through AI wet and dry loops, driving a paradigm upgrade in biomanufacturing.
Aug 2, 2026
Fc affinity resin; Fc-binding ligand; Fc region antibody purification resin from molecular recognition to industrial applications
The gold standard for antibody purification is Protein A affinity chromatography, and its core lies in the precise 'molecular handshake' between the Fc region and the ligand — this conservation amid all the variations makes it possible to achieve 95% purity in just one purification step, supporting the massive production capacity of the global antibody industry. From natural proteins to AI-designed engineered ligands, every breakthrough at the molecular level is reshaping the efficiency limits of biomanufacturing.
Aug 2, 2026
Low-Aggregating Protein A Resins: A Solution to the Aggregate Problem for Bispecific and Multispecific Antibodies?
Low-aggregation Protein A resins are shaking up antibody purification. With gentle elution and smart separation working together, they directly remove 70% of aggregates during the capture stage, protecting antibody activity while boosting purity. It's not just a tech upgrade—it’s a leap from fixing problems after the fact to controlling them right from the source.
Aug 2, 2026
High pH elution of Protein A resins: the end of 'low acid shock' in antibody purification?
Traditional Protein A purification relies on low pH elution, which can cause antibody aggregation and loss of activity. The new high pH elution media break through this technical bottleneck, allowing efficient dissociation under mild conditions of pH 4.0-5.0. This provides a safer purification solution for complex molecules like bispecific antibodies, balancing both yield and quality improvements.
Jul 30, 2026
The Five Generations of Affinity Ligand Evolution: From Natural Extraction to Protein Large-Scale Model Design
From natural extraction to AI design, the iteration of affinity ligands is taking biopharmaceutical purification from a 'trial-and-error' stage to a 'custom-on-demand' era. Protein large models break through the limitations of natural sequences, making it possible to design original ligands that are alkali-resistant, high-loading, and super-specific, completely reshaping the technical barriers and industry logic of the filler sector.
Jul 30, 2026
Antibody Capture/Monoclonal Antibody Purification/IgG Purification: The Core Role of Protein A Media in Antibody Production
Protein A resin is the 'gold standard' starting point in the antibody industry, capturing antibodies in one step with over 95% purity, supporting the production of hundreds of monoclonal antibody drugs worldwide. AI-driven custom design is speeding up the development of the next generation of high-performance resins, making antibody purification more efficient and accurate.Protein A resin for antibody capture;Protein A resin for mAb capture;Protein A resin for mAb purification;Protein A resin for IgG purification
Jul 30, 2026
Mild pH Elution of Protein A Resins: A Flexible Revolution in Antibody Purification
mild elution Protein A resin; mild pH elution Protein A resin; A Flexible Revolution in Antibody Purification
Jul 30, 2026
In-Depth Look at GMP-Grade Chromatography Media: Why Antibody Capture Media are the 'Cost Bottleneck' of Biologics?
GMP-grade chromatography resin; antibody capture resin; capture chromatography resin; affinity ligand protein
Jul 29, 2026
Low shedding / high flow / high throughput: The 3D performance upgrade of next-gen Protein A resins
low ligand leakage Protein A resin; low Protein A leaching resin; high-flow Protein A resin; high-throughput Protein A resin supplies and manufacturer
Jul 29, 2026
Enzyme Mining: The Lifeblood of Green Biomanufacturing
Enzymes are the core driving force behind green manufacturing and synthetic biology, but there are only about 60 types used industrially worldwide. AI-powered enzyme discovery is breaking traditional limits, cutting development cycles by over 60% and pinpointing industrial enzymes that are heat-resistant and highly active, boosting upgrades in industries like biomedicine and environmental protection worth hundreds of billions.
Jul 28, 2026
Enzyme Directed Evolution: Can AI End the Era of Trial and Error?
AI-driven directed evolution of enzymes breaks natural limits. Three rounds of experiments boosted catalytic efficiency by 8 times. From a 'broad net' to 'precision strike,' industrial enzymes can now work efficiently even under extreme conditions. Enzyme mining, enzyme modification, enzyme discovery, enzyme design—all powered by the AI enzyme intelligence tool: MatwingsVenus
Jul 28, 2026
Analysis and Application of Directed Protein Evolution Technology
Directed evolution of proteins compresses millions of years of natural evolution into just a few weeks, and the 2018 Nobel Prize in Chemistry recognized its groundbreaking value. By creating mutant libraries and using high-throughput screening, humans can precisely design industrial enzymes, optimize antibody drugs, and modify research tool proteins. AI technology is now breaking through the limitations of traditional blind screening, enabling precise prediction of mutations and multi-metric optimization, boosting protein R&D efficiency even more.
Jul 28, 2026
Protein design, what exactly is it?
Protein design is basically humans actively writing the 'code' of life. With AI, we can create proteins from scratch that have never existed in nature, driving trillion-dollar changes in biopharma, industrial enzymes, and more. Moving from 'understanding' to 'creating,' AI is taking design success from theoretical ideas to practical industrial use, and in the future, it'll reshape the boundaries of bio-manufacturing.
Jul 27, 2026
Overview of Protein Engineering
From tweaking natural proteins to using AI to design entirely new life molecules, protein engineering is breaking the limits of nature and driving changes in medicine, industry, and agriculture. AI-powered precise design is solving the tricky balance between activity and stability, cutting antibody development time from years to months—humans are now holding the tech key to reshaping the core of life.
Jul 27, 2026
Protein Function Prediction: Smart Decoding from Sequence to Function
Over 99% of protein functions still haven't been experimentally verified, and hundreds of new GO function categories are added every year. From traditional homology-based methods to cutting-edge multimodal AI reasoning, protein function prediction is using zero-shot learning and multimodal fusion to systematically decode billions of 'dark matter' proteins, providing a digital acceleration engine for biomedicine and synthetic biology.
Jul 27, 2026
Selection Logic for MabSelect SuRe Alternatives & MabSelect PrismA X Alternatives – Cytiva Protein A Resin Alternatives
From MabSelect SuRe to PrismA X, Cytiva's Protein A resins have gone through three generations of innovation: breaking alkali resistance limits, boosting capacity by 50%, and achieving super high performance with 80 mg/mL in short retention times. Domestic alternatives have already reached 60-80 mg/mL capacity, and alkali-tolerant ligand technology is helping upgrade biopharmaceutical purification processes.
Jul 27, 2026
High-capacity Protein A resin and alkali-resistant Protein A resin double-wheel drive: AI-driven technological evolution
Protein A affinity chromatography resins are essential materials for purifying antibody drugs. High capacity and alkali resistance are key for the new generation of technology—the first affects production efficiency, and the second impacts lifespan. With the help of the AI protein design platform MatwingsVenus , they managed to quadruple the alkali resistance in just four months, cutting the traditional development cycle from years to months, offering a revolutionary solution to reduce costs and increase efficiency in antibody industrial production.
Jul 26, 2026
Bioprocess chromatography resin downstream purification resin biopharma chromatography resin process-scale chromatography resin: How AI is reshaping high-end purification consumables development
Chromatography fillers are like the ‘invisible chips’ of biopharmaceuticals. From biological separation to industrial production, the four big names are all based on the same core material. AI protein design is cutting the traditional 2–5 year R&D cycle down to just 6 months, breaking through industrial performance bottlenecks like alkali resistance and load capacity, and speeding up domestic replacement.
Jul 26, 2026
In-Depth Look at Affinity Chromatography Resins/Media/Purification Materials: How AI Boosts Protein Purification Efficiency
In antibody drug production, 50%-70% of costs go into downstream purification, so it's the perfect time for domestic alternatives in the billion-dollar affinity chromatography market. AI technology is tackling the industry's big pain points—alkali resistance, customization, and shedding rate—cutting the traditional 2-5 year R&D cycle down to 6 months and helping China move from 'following' to a new 'customized and intelligent' track.
Jul 24, 2026
From Natural Protein to Industrial Tool: The Industrial Evolution of Protein A Affinity Ligands
Protein A ligand proteins are the 'molecular grabbers' for antibody purification, allowing antibody purity to reach over 95% in a single step. AI-driven engineering makes the ligands more alkali-resistant and efficient, raising the elution pH to 5.0 and speeding up industrial production of antibody drugs. Engineered Protein A ligands; Protein A ligand proteins; Protein A affinity ligands.
Jul 23, 2026
Next-Generation Protein A Chromatography Media: High Load, Alkali-Resistant, and the AI-Driven Path to Domestic PrismA Alternatives
Domestic Protein A fillers are hitting a key turning point to replace the imported benchmark PrismA — AI protein design technology is breaking through traditional R&D bottlenecks, reshaping the antibody purification industry with lower costs, better performance, and more stable supply chains.
Jul 23, 2026
Industrial enzymes: Green manufacturing biocatalysts, AI dry-wet closed-loop reshaping local industry patterns
Industrial enzymes are reshaping modern industry: with their efficient catalysis and eco-friendly, low-energy traits, they are replacing traditional chemical processes across dozens of fields like food, textiles, and pharmaceuticals. AI-driven enzyme design is revolutionizing the field, breaking through plastic-degrading enzyme bottlenecks in just 6 months, and domestically produced diagnostic enzymes now reach 98% purity. The global market is expected to hit $8.19 billion by 2026, with China leading the growth, ushering in a new era of bio-manufacturing.
Jul 22, 2026
The technological upgrades and industry value of protein a affinity
Protein A affinity chromatography is the 'soul step' of antibody purification, capturing over 95% pure antibodies in a single step. From natural proteins to AI-designed recombinant ligands, the molecular engineering inside these tiny beads is rapidly reshaping the biopharmaceutical supply chain.
Jul 22, 2026
MabSelect PrismA Alternative : Technology Evolution and Localization of Protein A Affinity Resins
Protein A resins are the gold standard for antibody purification, and Cytiva's MabSelect PrismA has become the industry benchmark thanks to its high capacity, alkali resistance, and stability. With AI-driven protein design technology, domestic alternatives are shifting from passively matching global standards to actively innovating beyond them, achieving both supply chain independence and performance breakthroughs. Matwings Technology's self-developed PROTEIN A series is a great option.
Jul 22, 2026